CLEAR EYES Maximum Itchy Eye Relief Recall Issued
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Prestige Brands Holdings is recalling 39,060 bottles of CLEAR EYES Maximum Itchy Eye Relief due to lack of assurance of sterility and potential contamination.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 25, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Prestige Brands Holdings initiated a voluntary recall of CLEAR EYES Maximum Itchy Eye Relief due to lack of assurance of sterility. The recall is due to potential contamination.
Which Products Are Affected
The affected product is CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per dropper bottle, Sterile, Dist. by Medtech Products Inc., Tarrytown, NY 10591, a Prestige Consumer Healthcare Company. NDC: 67172-999-01, UPC 6 78112 65920 3. Lot 2552A, Exp 09/30/2027. A total of 39,060 15mL-bottles are affected. Distribution was nationwide in the USA.
What You Should Do
This is a Class II recall initiated by the firm via letter. Consumers should verify the lot number on purchased units.
Why This Matters
The recall affects over 39,000 bottles distributed nationwide, addressing a potential sterility issue in an over-the-counter ophthalmic product.
Source
FDA recall number D-0766-2026. Data from FDA enforcement report.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (963 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 25, 2026.
Frequently Asked Questions
Common questions about this FDA recall.